Rapt Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy RAPT

*Your capital is at risk

$58.02

+0 (+0%)

At Close: Jun 01, 2026

RAPT Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -42.46. In total, the insiders bought 7.63M and sold 1.29M RAPT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-42.46
● Buy	7.63M shares
● Sell	1.29M shares
38% Buy Activity Negligible or No Correlation
Sell Signal Medium Confidence Mar 03, 2026 Analysis Breakdown: Supported by a negative Insider Power Score of -42.46. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 21, 2025 Buy	Director Stock Option (right to buy) A-Award	Braunstein Scott Director	Director	25 000 Value: $185.8K
Jun 20, 2025 Buy	Employee Stock Option (right to buy) A-Award	Ho William Chief Medical Officer	Officer	75 000 Value: $557.3K
Jun 20, 2025 Buy	Employee Stock Option (right to buy) A-Award	Wong Brian Russell President And CEO	CEO / President	637 500 Value: $4.74M
Jun 20, 2025 Buy	Employee Stock Option (right to buy) A-Award	Young Rodney Kb Chief Financial Officer	C-Suite Officer	118 750 Value: $882.3K
Jun 20, 2025 Buy	Employee Stock Option (right to buy) A-Award	Brockstedt Dirk G. Chief Scientific Officer	Officer	100 000 Value: $743.0K
Jun 20, 2025 Buy	Employee Stock Option (right to buy) A-Award	Brockstedt Dirk G. Chief Scientific Officer	Officer	100 000 Value: $743.0K
Jun 20, 2025 Buy	Employee Stock Option (right to buy) A-Award	Young Rodney Kb Chief Financial Officer	C-Suite Officer	118 750 Value: $882.3K
Jun 20, 2025 Buy	Employee Stock Option (right to buy) A-Award	Wong Brian Russell President And CEO	CEO / President	637 500 Value: $4.74M
Jun 20, 2025 Buy	Employee Stock Option (right to buy) A-Award	Ho William Chief Medical Officer	Officer	75 000 Value: $557.3K
May 29, 2025 Buy	Director Stock Option (right to buy) A-Award	Giordano Michael F Director	Director	257 832 Value: $239.8K
May 29, 2025 Buy	Director Stock Option (right to buy) A-Award	Gray Mary Ann Director	Director	257 832 Value: $239.8K
May 29, 2025 Buy	Director Stock Option (right to buy) A-Award	Lyons-williams Lori Director	Director	257 832 Value: $239.8K
May 29, 2025 Buy	Director Stock Option (right to buy) A-Award	Kozick Linda Director	Director	257 832 Value: $239.8K
May 29, 2025 Buy	Director Stock Option (right to buy) A-Award	Kozick Linda Director	Director	257 832 Value: $239.8K
May 29, 2025 Buy	Director Stock Option (right to buy) A-Award	Lyons-williams Lori Director	Director	257 832 Value: $239.8K
May 29, 2025 Buy	Director Stock Option (right to buy) A-Award	Gray Mary Ann Director	Director	257 832 Value: $239.8K
May 29, 2025 Buy	Director Stock Option (right to buy) A-Award	Giordano Michael F Director	Director	257 832 Value: $239.8K
Mar 31, 2025 Buy	Director Stock Option (right to buy) A-Award	Robbins Wendye Director	Director	49 432 Value: $60.3K
Mar 31, 2025 Buy	Director Stock Option (right to buy) A-Award	Gray Mary Ann Director	Director	61 202 Value: $74.7K
Mar 31, 2025 Buy	Director Stock Option (right to buy) A-Award	Gray Mary Ann Director	Director	61 202 Value: $74.7K
Mar 31, 2025 Buy	Director Stock Option (right to buy) A-Award	Robbins Wendye Director	Director	49 432 Value: $60.3K
Jan 30, 2025 Buy	Employee Stock Option (right to buy) A-Award	Ho William Chief Medical Officer	Officer	450 000 Value: $513.0K
Jan 30, 2025 Buy	Employee Stock Option (right to buy) A-Award	Young Rodney Kb Chief Financial Officer	C-Suite Officer	642 000 Value: $731.9K
Jan 30, 2025 Buy	Employee Stock Option (right to buy) A-Award	Brockstedt Dirk G. Chief Scientific Officer	Officer	515 000 Value: $587.1K
Jan 30, 2025 Buy	Employee Stock Option (right to buy) A-Award	Wong Brian Russell President And CEO	CEO / President	1 746 000 Value: $1.99M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT RAPT THERAPEUTICS, INC.

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead onco...

Read Full Profile Here